6-氯-2-氯甲基咪唑并[1,2-a]吡啶 、 1-(3-Chlorophenyl)piperazine-1,4-diium;dichloride 、 三乙胺 以
乙二醇 为溶剂,
以give 0.372 g of the title compound的产率得到6-Chloro-2-[[4-(3-chlorophenyl)-1-piperazinyl]methyl]-imidazo[1,2-a]pyridine
参考文献:
名称:
Imidazo\x9b1,2-a!pyridines for the treatment of CNS and cardiac diseases
IMIDAZO 1,2-A]PYRIDINES FOR THE TREATMENT OF CNS AND CARDIAC DISEASES
申请人:PHARMACIA & UPJOHN COMPANY
公开号:EP0809642A1
公开(公告)日:1997-12-03
US6013654A
申请人:——
公开号:US6013654A
公开(公告)日:2000-01-11
[EN] IMIDAZO[1,2-A]PYRIDINES FOR THE TREATMENT OF CNS AND CARDIAC DISEASES<br/>[FR] IMIDAZO[1,2-A]PYRIDINES POUR LE TRAITEMENT DU SNC ET DE CARDIOPATHOLOGIES
申请人:PHARMACIA & UPJOHN COMPANY
公开号:WO1996025414A1
公开(公告)日:1996-08-22
(EN) The present invention relates to imidazo[1,2-a]pyridine compounds of formula (I), which are dopamine D-4 antagonists and useful as anti-psychotic agents.(FR) La présente invention concerne des composés imidazo[1,2-a]pyridine de formule I antagonistes de la dopamine D-4 et efficaces comme neuroleptiques.